Figure S2 from Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models
Authors:
- Hirokazu SuzukiHSHirokazu Suzuki
- Shotaro NagaseSNShotaro Nagase
- Chiemi SaitoCSChiemi Saito
- Atsuko TakatsukaATAtsuko Takatsuka
- Motoko NagataMNMotoko Nagata
- Kokichi HondaKHKokichi Honda
- Yuki KanedaYKYuki Kaneda
- Yumi NishiyaYNYumi Nishiya
- Tomoyo HondaTHTomoyo Honda
- Tomomichi IshizakaTITomomichi Ishizaka
- Kensuke NakamuraKNKensuke Nakamura
- Takashi NakadaTNTakashi Nakada
Open Access
- 4 March 2024
- other
- Published by American Association for Cancer Research (AACR)